Carson Wealth (CWM LLC)’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.8M | Sell |
5,512
-11,152
| -67% | -$3.64M | 0.01% | 991 |
|
|
2025
Q1 | $4.5M | Buy |
16,664
+3,473
| +26% | +$938K | 0.02% | 558 |
|
|
2024
Q4 | $3.1M | Buy |
13,191
+6,427
| +95% | +$1.51M | 0.01% | 610 |
|
|
2024
Q3 | $1.86M | Buy |
6,764
+3,272
| +94% | +$900K | 0.01% | 736 |
|
|
2024
Q2 | $849K | Buy |
3,492
+1,770
| +103% | +$430K | ﹤0.01% | 982 |
|
|
2024
Q1 | $257K | Sell |
1,722
-41,678
| -96% | -$6.22M | ﹤0.01% | 1397 |
|
|
2023
Q4 | $8.31M | Sell |
43,400
-538
| -1% | -$103K | 0.04% | 294 |
|
|
2023
Q3 | $7.78M | Sell |
43,938
-1,436
| -3% | -$254K | 0.05% | 280 |
|
|
2023
Q2 | $8.62M | Buy |
45,374
+43,648
| +2,529% | +$8.29M | 0.05% | 248 |
|
|
2023
Q1 | $346K | Sell |
1,726
-193
| -10% | -$38.7K | ﹤0.01% | 1011 |
|
|
2022
Q4 | $456K | Sell |
1,919
-1,044
| -35% | -$248K | ﹤0.01% | 835 |
|
|
2022
Q3 | $593K | Sell |
2,963
-410
| -12% | -$82.1K | ﹤0.01% | 700 |
|
|
2022
Q2 | $492K | Sell |
3,373
-6,579
| -66% | -$960K | ﹤0.01% | 735 |
|
|
2022
Q1 | $1.63M | Sell |
9,952
-2,046
| -17% | -$334K | 0.01% | 443 |
|
|
2021
Q4 | $2.04M | Buy |
+11,998
| New | +$2.04M | 0.01% | 427 |
|
|
2021
Q2 | $2.02M | Hold |
11,896
| – | – | 0.02% | 422 |
|
|
2021
Q1 | $2.02M | Hold |
11,896
| – | – | 0.02% | 422 |
|
|
2020
Q4 | $2.02M | Hold |
11,896
| – | – | 0.02% | 422 |
|
|
2020
Q3 | $2.02M | Hold |
11,896
| – | – | 0.02% | 422 |
|
|
2020
Q2 | $2.02M | Hold |
11,896
| – | – | 0.02% | 422 |
|
|
2020
Q1 | $2.02M | Hold |
11,896
| – | – | 0.02% | 422 |
|
|
2019
Q4 | $2.02M | Hold |
11,896
| – | – | 0.02% | 422 |
|
|
2019
Q3 | $2.02M | Hold |
11,896
| – | – | 0.02% | 422 |
|
|
2019
Q2 | $2.02M | Hold |
11,896
| – | – | 0.02% | 422 |
|
|
2019
Q1 | $2.02M | Buy |
+11,896
| New | +$2.02M | 0.02% | 422 |
|